Nasal booster

Bharat Biotech Gets Nod for trial of COVID nasal booster dose

DCGI's Subject Expert Committee (SEC) gave an ‘in-principle' approval to Bharat Biotech for the 'phase-III booster dose study' for its intranasal Covid vaccine